USPTO Biotech/Chemical Partnership (BCP) Meetings

In This Section

Biotechnology/Chemical/Pharmaceutical (BCP) Customer April 17, 2001

Apr 17, 2001, 09:00 AM by AIPLA Admin

United States Patent and Trademark Office
Arlington, Virginia 22202
Patent Academy Room 1, Crystal Square 4, 7th Floor

 

Morning Session  
9:00 – 9:30 AM

Opening Remarks

Jasemine Chambers
John Doll
Directors TC 1600
9:30 – 10:10 AMThe Electronic Filing System  (421K)

Mary Small, Search and Information Resources Administration (SIRA)

10:10 – 10:30 AMBreak 
10:30 – 10:50 AMNew Amendment Format,  (36K) and  TC 1600 Customer Service Center   (565K) Helen Childs/Margaret Stevens, Head Supervisory Legal Instruments Examiners, TC 1600
10:50 – 11:20 AM Pre-Grant Publications  (1,020K) Hiram Bernstein, Legal Advisor, Office of Patent Legal Administration
11:20 - 11:30 AMClosing Remarks (morning session) 
11:30 AM to 1:00PMLunch  
Afternoon Session  
1:00 - 1:10Introductory Remarks 
1:10 – 1:45 PM Chemical Claim Language/Red Flag Terms (79K) Joseph McKane, Supervisory Patent Examiner, TC 1600
1:45 – 2:20 PMPharmaceutical Compositions and Enablement  (62K) Robert Hill, Quality Assurance Specialist, TC 1600
2:20 – 2:40 PM Break 
2:40 – 3:15 PMExamination Practice in the Single Nucleotide Polymorphisms (SNP) Art (699K) Gary Jones, Supervisory Patent Examiner, TC 1600
3:15 – 3:50 PMSequence Homology and Prediction of Function  (458K) James Martinell, Senior Level Examiner, TC 1600
3:50 – 4:00 PMClosing Remarks Jasemine Chambers
John Doll
Directors TC 1600